Sort
78,016 grants matching “breast cancer”
LONG TERM OUTCOMES FOR WOMEN WITH BREAST CA IN SITU
$576,560Yale University · R01 · FY2001 · CA
Stanford University NCTN- Network Lead Academic Site
$576,471Heather Ann Wakelee · Stanford University · U10 · FY2015 · CA
Stanford University NCTN- Network Lead Academic Site
$576,471Heather Ann Wakelee · Stanford University · U10 · FY2014 · CA
Project 3: Enhanced Sensitivity of Tumors to Proton Beam Therapy: Mechanisms and Biomarkers.
$576,447David R Grosshans · Massachusetts General Hospital · P01 · FY2024 · CA
Defining Cancer Intervention Targets by Functional Genomics Analysis of Outbred F1 Mice
$576,403Jennifer B Jacob · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2025 · CA
HRT USE AND RISK OF LOBULAR AND DUCTAL BREAST CANCER
$576,393Fred Hutchinson Cancer Research Center · R01 · FY2001 · CA
Tension-Stat3-miR-mediated metastasis
$576,372Valerie Marie Weaver · University Of California, San Francisco · R01 · FY2017 · CA
Project 2: Molecular and Clinical Inputs Affecting Optimization of Glioma Therapy
$576,371Eric C Holland · Dana-Farber Cancer Inst · U54 · FY2017 · CA
The integrated mechanobiology and glycobiology of bone metastasis
$576,337Claudia Fischbach · Cornell University · R01 · FY2025 · CA
To enhance breast cancer survivorship of Asian Americans
$576,313Eun-Ok Im · Emory University · R01 · FY2020 · CA
Developing DOSI Technology for Monitoring Response To Breast Cancer Chemotherapy
$576,227Bruce J Tromberg · University Of California-Irvine · R01 · FY2012 · CA
Histone Methyltransferases as a Target for Lung Cancer Prevention
$576,204Steven A Belinsky · Lovelace Biomedical & Environmental Research Institute · R01 · FY2014 · CA
To enhance breast cancer survivorship of Asian Americans
$576,193Eun-Ok Im · Duke University · R01 · FY2018 · CA
Heartland Cancer Research CCOP
$576,180Alan P Lyss · Missouri Baptist Medical Center · U10 · FY2009 · CA
Molecular Imaging and Targeted Therapy of HER2-Positive Breast Cancers
$576,145Jacek Capala · Division Of Basic Sciences - Nci · ZIA · FY2011 · CA
Proteolytic Control of Oncoprotein Function
$576,079William Patrick Tansey · Cold Spring Harbor Laboratory · P01 · FY2008 · CA
DISSECTING THE MECHANISMS OF DRUG RESISTANCE IN BRCA1/2-MUTANT BREAST CANCERS
$576,041The Geneva Foundation · · FY2016 · Department of the Army
Vanderbilt Clinical Oncology Res.Career Develop.Program
$576,036Vanderbilt University · K12 · FY2003 · CA
Vanderbilt Clinical Oncology Res.Career Develop.Program
$576,036Vanderbilt University · K12 · FY2002 · CA
Vanderbilt Clinical Oncology Res.Career Develop.Program
$576,036Vanderbilt University · K12 · FY2004 · CA
HER2-mediated delivery of cytotoxic agents in solid tumors
$576,031Bob T Li · Sloan-Kettering Inst Can Research · R01 · FY2023 · CA
HER2-mediated delivery of cytotoxic agents in solid tumors
$576,029Bob T Li · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
VALIDATION OF AN IN VITRO ASSAY FOR ANDROGENIC ACTIVITY
$576,013Cathy Z Yang · Certichem, Inc. · R44 · FY2016 · ES
The Lymphedema and Gynecologic Cancer (LEG) Study: Incidence, Risk Factors, and
$576,010Richard R Barakat · Sloan-Kettering Inst Can Research · R01 · FY2011 · CA
Pharmacogenomic and circulating tumor cell approach to individualized treatment of pancreatic cancer
$575,997Kenneth H. Yu · Sloan-Kettering Inst Can Research · R01 · FY2020 · CA